Robust tumor immunity to melanoma mediated by interleukin-9–producing T cells-Reference-Cited by-同舟云学术

Robust tumor immunity to melanoma mediated by interleukin-9–producing T cells

Published:2012-07-08 Issue:8 Volume:18 Page:1248-1253
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Purwar Rahul,Schlapbach Christoph,Xiao Sheng,Kang Hong Soon,Elyaman Wassim,Jiang Xiaodong,Jetten Anton M,Khoury Samia J,Fuhlbrigge Robert C,Kuchroo Vijay K,Clark Rachael A,Kupper Thomas S

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2856.pdf

Reference42 articles.

1. Hodi, F.S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711–723 (2010).

2. Topalian, S.L. et al. Safety, activity, and immune correlates of anti–PD-1 antibody in cancer. N. Engl. J. Med. published online doi:10.1056/NEJMoa1200690 (2 June 2012).

3. Mumberg, D. et al. CD4+ T cells eliminate MHC class II–negative cancer cells in vivo by indirect effects of IFN-γ. Proc. Natl. Acad. Sci. USA 96, 8633–8638 (1999).

4. Perez-Diez, A. et al. CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 109, 5346–5354 (2007).

5. Quezada, S.A. et al. Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J. Exp. Med. 207, 637–650 (2010).

Cited by 353 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with 1.25% cholesterol enriched diet produces severe fatty liver disease characterized by advanced fibrosis and inflammation and impaired autophagy in mice;The Journal of Nutritional Biochemistry;2024-12

2. Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy;Frontiers in Immunology;2024-08-30

3. Fatty acid metabolism constrains Th9 cell differentiation and antitumor immunity via the modulation of retinoic acid receptor signaling;Cellular & Molecular Immunology;2024-08-26

4. TTK inhibitor OSU13 promotes immunotherapy responses by activating tumor STING;JCI Insight;2024-06-20

5. The emerging role of T helper 9 (Th9) cells in immunopathophysiology: A comprehensive review of their effects and responsiveness in various disease states;International Reviews of Immunology;2024-06-12